Monoclonal Rat anti-Mouse CD90.2 (Mouse) Antibody (clone 30H12, AF647)
Catalog Number: LS-C810655
2 sizes / from $259.00
Antibody: Rat Monoclonal
Applications: Flow Cytometry
Reactivity: Mouse
Format: Liquid
Monoclonal Mouse anti-Human TRIP230 / TRIP11 Antibody (clone 10G5, Preservative Free, aa1099-1372, WB)
Primary AntibodyLSBio Guarantee
| Antibody: | Mouse Monoclonal |
| Applications: | Immunohistochemistry (general), Immunoprecipitation, Western Blot |
| Reactivity: | Human |
| Format: | Liquid |
$459.00each
Catalog Number: LS-C20059-100
Catalog Number: LS-C20059
For bulk orders or custom formulations:
Request a QuoteOverview
- Description
- TRIP11 antibody LS-C20059 is an unconjugated mouse monoclonal antibody to human TRIP11 (TRIP230) (aa1099-1372). Validated for IP and WB. Cited in 1 publication.
- Application
- IHC, IP, WB
- Reactivity
- Hu
- Intended Use
- Research Use Only
- Guarantees
- This antibody carries the LSBio 100% Guarantee. ✓
- Category
- Antibodies > Primary Antibodies > Monoclonal Antibodies
- Alternative Names
- ACG1A | GMAP-210 | TR-interacting protein 11 | TRIP230 | TRIP-11 | TRIP11 | CEV14
- UniProt Number
- Q15643
- NCBI GenBank
- NM_004239 | NP_004230.2
- SwissProt
- Q15643
Target
- Target
- Human TRIP230 / TRIP11
- Antigen Species
- Human
- Epitope
- Amino acids 1099-1372 of Trip230 expressed in E. coli.
- Gene Name
- TRIP11
Antibody
- Host Species
- Mouse
- Clonality
- Monoclonal
- Clone
- 10G5
- Isotype
- IgG1
Immunogen
- Immunogen
- Amino acids 1099-1372 of Trip230 expressed in E. coli.
- Immunogen Type
- Recombinant Protein Fragment
Format
- Conjugate/Label
- Unconjugated
- Format
- Liquid
- Formulation
- PBS, pH 7.4
- Concentration
- 1 mg/mL
- Volume
- 100 Microliter
- Preservative
- No
- Purification Method
- Protein G Affinity
Storage & Handling
- Storage Conditions
- Short term: store at 4°C. Long term: aliquot and store at -20°C. Avoid freeze-thaw cycles. Store undiluted.
- Recommended Storage Buffer
- PBS
The skeletal phenotype of achondrogenesis type 1A is caused exclusively by cartilage defects. Bird IM, Kim SH, Schweppe DK, Caetano-Lopes J, Robling AG, Charles JF, Gygi SP, Warman ML, Smits PJ. Development (Cambridge, England). 2018 January;145:pii: dev156588. PubMed: 29180569 PMC: PMC5825869
